Infliximab-induced urticaria.
Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Barry
B
Ladizinski
Department of Dermatology, Brown University, Providence, Rhode Island.
Kachiu C
KC
Lee
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000069285:Infliximab; D014581:Urticaria / Q000139:chemically induced*; D055815:Young Adult
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D000069285:Infliximab